MODERN MARKERS OF GESTATIONAL DIABETES MELLITUS: ADVANTAGES AND DISADVANTAGES
https://doi.org/10.35266/2949-3447-2023-4-1
Abstract
The study aims to generalize and systematize information obtained from the literature of 10 years from the MEDLINE, PubMed, eLIBRARY.RU, and RISC databases about additional markers of glycemic control in gestational
diabetes mellitus for evaluation of its effectiveness and treatment correction. The review article included 22 literature sources out of 156 analyzed publications on the issue. There is not enough research available on such markers as fructosamine, glycated albumin, and 1.5-anhydroglucitol. Therefore, it is required to study and implement them into practice further on in order to optimize the treatment and manage pregnancies with gestational diabetes mellitus.
About the Authors
Larisa D. Belotserkovtseva
Surgut State University, Surgut;
Surgut District Clinical Center of Maternity and Childhood Health Care, Surgut
Russian Federation
Russian Federation
Doctor of Sciences (Medicine), Professor
Elena N. Erchenko
Surgut State University, Surgut;
Surgut District Clinical Center of Maternity and Childhood Health Care, Surgut
Russian Federation
Russian Federation
Candidate of Sciences (Medicine), Docent, Obstetrician-Gynecologist
Lyaysan F. Khisamieva
Surgut State University, Surgut
Russian Federation
Russian Federation
Postgraduate, Obstetrician-Gynecologist
References
1. Dias S., Pheiffer C., Abrahams Y. et al. Molecular biomarkers for gestational diabetes mellitus. Int J Mol Sci. 2018;19(10):2926.
2. Mendes N., Tavares Ribeiro R., Serrano F. Beyond self-monitored plasma glucose and HbA1c: The role of non-traditional glycaemic markers in gestational diabetes mellitus. J Obstet Gynaecol. 2018;38(6):762–769.
3. Гестационный сахарный диабет. Диагностика, лечение, акушерская тактика, послеродовое наблюдение : клинич. рекомендации. 2020. 53 с.
4. Mendes N., Alves M., Andrade R. et al. Association between glycated haemoglobin, glycated albumin and fructosamine with neonatal birthweight and large-for-date status infants in gestational diabetes mellitus: A prospective cohort study. J Obstet Gynaecol. 2019;39(6):768–773.
5. Modzelewski R., Stefanowicz-Rutkowska M., Matuszewski W. et al. Gestational diabetes mellitus – Recent literature review. J Clin Med. 2022;11(19):5736.
6. Конченкова Е. Н., Белоцерковцева Л. Д., Коваленко Л. В. Диагностика и гликемический контроль гестационного сахарного диабета: реалии и перспективы // Вестник СурГУ. Медицина. 2019. № 2. С. 75–85.
7. Mao Z., Wu R, Yu H. et al. Associations of maternal fructosamine before delivery in gestational diabetes mellitus pregnancies with neonatal glucometabolic disorders. J Diabetes Res. 2022;2022:2478250.
8. Hashimoto K., Koga M. Indicators of glycemic control in patients with gestational diabetes mellitus and pregnant women with diabetes mellitus. World J Diabetes. 2015;6(8):1045–1056.
9. Macrosomia: ACOG Practice Bulletin, Number 216. Obs Gynecol. 2020;135:e18–e35.
10. Colagiuri S., Falavigna M., Agarwal N. M. et al. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: A World Health Organization Guideline. Journal of Diabetes Research and Clinical Practice. 2014;103:341–363.
11. Zhu J., Chen Y., Li C. et al. The diagnostic value of glycated albumin in gestational diabetes mellitus. J Endocrinol Invest. 2018;41(1):121–128.
12. Ribeiro R. T., Macedo M. P., Raposo J. F. HbA1c, fructosamine, and glycated albumin in the detection of dysglycaemic conditions. Curr Diabetes Rev. 2016;12(1):14–19.
13. American Diabetes Association. Standards of medical care in diabetes – 2019. Diabetes Care. 2019. Vol. 42, Suppl 1. 193 p.
14. Petrovic O., Belci D. A critical appraisal and potentially new conceptual approach to screening and diagnosis of gestational diabetes. J Obstet Gynaecol. 2017;37(6):691–699.
15. Danese E., Montagnana M., Nouvenne A. et al. Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes. J Diabetes Sci Technol. 2015;9(2):169–176.
16. Sousa A. M., Fiuza D., Mikami F. C. F. et al. Evaluation of information retention and adherence to treatment in patients with gestational diabetes mellitus after multidisciplinary group. Rev Assoc Med Bras (1992). 2016;62(3):212–217.
17. Daraki V., Roumeliotaki T., Koutra K. et al. Effect of parental obesity and gestational diabetes on child neuropsychological and development at 4 years of age: The Rhea mother-child cohort, Crete, Greece. Eur Child Adolesc Psychiatry. 2017;26(6):703–714.
18. Alejandro E. U., Mamerto T. P., Chung G. et al. Gestational diabetes mellitus: A harbinger of the vicious cycle of diabetes. Int J Mol Sci. 2020;21(14):5003.
19. IDF Diabetes atlas. 10th edition. Brussels, Belgium: International Diabetes Federation; 2021. URL: https://diabetesatlas.org/atlas/tenth-edition/ (дата обращения: 13.10.2023).
20. Petraglia F., Di Tommaso M., Mecacci F., editors. Hormones and pregnancy. Basic science and clinical implications. 2022. p. 208. URL: tinylinks.ru/iglm (дата обращения: 13.10.2023).
21. McIntyre H. D. Discovery knowledge and action diabetes in pregnancy across the transplational spectrum: Еhe 2016 Norbert Freinkel Award lecture. Diabetes Care. 2018;41(2):227–232.
22. American Diabetes Association Professional Practice Committee. 15. Management of Diabetes in pregnancy: Standards of medical care in diabetes–2022. Diabetes Care. 2022;45(Suppl 1):S232–S243.
Review
For citations:
Belotserkovtseva L.D., Erchenko E.N., Khisamieva L.F. MODERN MARKERS OF GESTATIONAL DIABETES MELLITUS: ADVANTAGES AND DISADVANTAGES. Vestnik SurGU. Meditsina. 2023;16(4):8-12. (In Russ.) https://doi.org/10.35266/2949-3447-2023-4-1
Views:
241
Email this article 
